GENTILINI, ORESTE DAVIDE
 Distribuzione geografica
Continente #
AS - Asia 2.961
EU - Europa 2.400
NA - Nord America 1.725
SA - Sud America 465
AF - Africa 40
OC - Oceania 5
Totale 7.596
Nazione #
US - Stati Uniti d'America 1.636
RU - Federazione Russa 1.507
SG - Singapore 1.237
CN - Cina 939
BR - Brasile 394
HK - Hong Kong 345
IT - Italia 312
VN - Vietnam 203
FR - Francia 161
DE - Germania 111
GB - Regno Unito 60
SE - Svezia 59
FI - Finlandia 54
IN - India 51
CA - Canada 48
BD - Bangladesh 47
AT - Austria 33
MX - Messico 30
NL - Olanda 28
TR - Turchia 24
JP - Giappone 21
AR - Argentina 20
PL - Polonia 20
PK - Pakistan 17
ZA - Sudafrica 17
ES - Italia 15
IQ - Iraq 15
EC - Ecuador 12
VE - Venezuela 12
SA - Arabia Saudita 11
CO - Colombia 8
LT - Lituania 8
ID - Indonesia 7
IE - Irlanda 7
DZ - Algeria 6
PE - Perù 6
PH - Filippine 6
TN - Tunisia 6
UA - Ucraina 6
NP - Nepal 5
PY - Paraguay 5
EG - Egitto 4
JO - Giordania 4
UZ - Uzbekistan 4
AU - Australia 3
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
MY - Malesia 3
PA - Panama 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GR - Grecia 2
KE - Kenya 2
KZ - Kazakistan 2
MA - Marocco 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.596
Città #
Singapore 656
San Jose 372
Hong Kong 344
Moscow 340
Ashburn 297
Dallas 218
Shanghai 187
Beijing 150
Hefei 132
Milan 119
Lauterbourg 112
Ho Chi Minh City 69
Hanoi 54
Los Angeles 52
New York 52
São Paulo 41
Nuremberg 39
Rome 39
Santa Clara 36
Council Bluffs 33
Boardman 26
Munich 26
Guangzhou 25
Chennai 22
Helsinki 22
Tokyo 19
Brooklyn 18
Lappeenranta 17
Montreal 17
Warsaw 16
Denver 15
Lawrence 15
Orem 15
Princeton 15
Rho 15
Turku 15
Rio de Janeiro 14
Chicago 13
Johannesburg 13
Poplar 13
Vienna 13
Assago 12
Boston 12
London 12
Phoenix 12
San Francisco 12
Toronto 11
Amsterdam 10
Da Nang 10
Falkenstein 10
Haiphong 10
Lahore 10
Mexico City 10
Shenzhen 10
Stockholm 10
Belo Horizonte 9
Baghdad 8
Brasília 8
Cesano Boscone 8
Curitiba 8
Manchester 8
Porto Alegre 8
Tianjin 8
Atlanta 7
Buffalo 7
Charlotte 7
Houston 7
Jeddah 7
Dublin 6
Mumbai 6
Paris 6
Seattle 6
Barnet 5
Erbil 5
Fortaleza 5
Frankfurt am Main 5
Jiaxing 5
Pune 5
Quito 5
Reston 5
St Louis 5
Washington 5
Wuxi 5
Ankara 4
Campinas 4
Dhaka 4
Duque de Caxias 4
Guarulhos 4
Guayaquil 4
Hangzhou 4
Jundiaí 4
Las Vegas 4
Lima 4
Miami 4
Naples 4
Ottawa 4
Philadelphia 4
Pittsburgh 4
Querétaro 4
Amman 3
Totale 4.103
Nome #
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study 151
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis 117
A single unit of transfused allogeneic blood increases postoperative infections 106
Coping Mechanisms, Psychological Distress, and Quality of Life Prior to Cancer Genetic Counseling 106
A randomized trial comparing sentinel lymph node biopsy vs. no axillary surgical staging patients with small breast cancer and a negative preoperative axillary assessment 102
Alternative alla trasfusione di sangue omologo nel paziente chirurgico oncologico 102
Is routine axillary lymph node dissection needed to tailor systemic treatments for breast cancer patients in the era of molecular oncology? A position paper of the Italian National Association of Breast Surgeons (ANISC) 97
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases 92
Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey 92
Pet/mri for staging the axilla in breast cancer: Current evidence and the rationale for snb vs. pet/mri trials 89
Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND) 88
[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial 88
Axillary observation alone versus sentinel node biopsy: Past, present and future perspectives 87
An integrated approach for the study of colorectal cancer: From methylome to transcriptome 86
A multidisciplinary approach for autologous breast reconstruction: A narrative (re)view for better management 86
Pregnancy After Breast Cancer in Young BRCA Carriers 86
Biomarkers for risk assessment and prevention of breast cancer 84
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial 84
Fibrin sealants and axillary lymphatic morbidity: A systematic review and meta-analysis of 23 clinical randomized trials 84
Weekly Paclitaxel Administered During a Twin Pregnancy for Recurrent Breast Cancer: Case Report and Review of the Literature 82
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges 82
Awareness is the key to conquering male breast cancer 82
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 81
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients with Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial 81
An integrated approach for the study of colorectal cancer: From methylome to transcriptome 80
Real-world use of multigene signatures in early breast cancer: differences to clinical trials 80
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 80
Breast cancer highlights from 2023: Knowledge to guide practice and future research 79
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment 79
Artificial nutrition after pancreaticoduodenectomy 79
Breast Cancer in Young Women 77
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer 77
Analysis of local and regional recurrences in breast cancer after conservative surgery 75
Brain metastases in breast cancer 74
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 73
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 72
ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) 71
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy 68
Evaluating the ability of an artificialintelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy: The CINDERELLA trial 65
Uncertainties and controversies in axillary management of patients with breast cancer 65
Theoretical and practical knowledge curriculum for European Breast Surgeons 65
The SOUND Randomized Clinical Trial Results - Reply 65
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) 64
Breast cancer in pregnancy: recommendations of an international consensus meeting 63
Not only volumes matter for breast radiation therapy 62
Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future 62
Real de-escalation or escalation in disguise? 61
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of view 60
Radical oncologic surgery affects the circulatory levels of interleukin 10 60
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak 60
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized? 60
Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients 59
Weekly epirubicin in the treatment of gestational breast cancer (GBC) 58
Surgical Management of Breast Cancer in Young Women 58
Surgical management of the axilla in clinically node‐positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: Current status, knowledge gaps, and rationale for the eubreast‐03 axsana study 58
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? 57
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox 57
Knowledge gaps in oncoplastic breast surgery 57
Surgery Following Primary Systemic Therapy: How to Increase Breast Conservation Rate 57
The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer 56
Breast-conserving surgery in 201 very young patients (<35 years) 55
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer 54
Managing pregnant women with cancer: personal considerations and a review of the literature 54
Erythropoiesis after therapy with recombinant human erythropoietin: A dose-response study in anemic cancer surgery patients 54
The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study 53
Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase III trial 53
Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anaemic patients with cancer of the gastrointestinal tract 53
Pathological features and survival outcomes of very young patients with early breast cancer: How much is “very young”? 52
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer 52
Micrometastases in the sentinel node after neoadjuvant therapy. Is axillary dissection still required? 52
De-escalation of loco-regional treatments: Time to find a balance 51
Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-sound) trial 51
Perioperative immunonutrition in patients undergoing cancer surgery - Results of a randomized double-blind phase 3 trial 51
Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution 50
Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting 50
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic 50
Sentinel node detection in pre-operative axillary staging 49
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 49
Hereditary Breast Cancer Non-CDH1 Associated 48
Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey 48
The clinical and pathological profile of BRCA1 gene methylated breast cancer women: A meta-analysis 48
Timing and Type of Breast Reconstruction in Young Breast Cancer Patients 48
Colorectal cancer early methylation biomarkers 48
Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery 48
Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients 48
Locoregional treatment of breast cancer during pregnancy 47
Lessons from the SOUND trial and future perspectives on axillary staging in breast cancer 47
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 47
Second international consensus guidelines for breast cancer in Young women (BCY2) 47
Sentinel lymph node biopsy in pregnant patients with breast cancer 46
Current Evolutions in Axillary Management 46
Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant women with early breast cancer? In vivo dosimetry to assess fetal dose 45
Male breast cancer 45
Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution 44
The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. 44
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? 44
Re: The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence 44
Immediate breast reconstruction with expander in pregnant breast cancer patients 44
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 43
Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology 43
Totale 6.573
Categoria #
all - tutte 41.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 2 0 0 0 1 4 0 0 0
2022/202384 35 23 7 0 0 10 2 4 3 0 0 0
2023/2024361 2 1 8 7 2 76 4 29 2 5 141 84
2024/20252.030 278 53 24 95 109 157 211 169 349 287 145 153
2025/20265.454 467 356 248 722 477 139 654 359 1.401 410 108 113
Totale 7.940